Food Science and Biotechnology

  • 제17권3호
  • /
  • Pages.598-602
  • /
  • 2008
  • /
  • 1226-7708(pISSN)
  • /
  • 2092-6456(eISSN)
한국식품과학회 (Korean Society of Food Science and Technology)
권호 표지

Immunosuppressive Properties of Catfish Bile from Silurus asotus: Inhibition of T Cell Activation in Mouse Splenocytes

  • Joo, Seong-Soo (Research Institute of Veterinary Medicine, Chungbuk National University)
  • 발행 : 2008.06.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Concentrated catfish Silurus asotus bile (SAB) containing high amounts of ursodeoxycholic acid (UDCA) and taurocholic acid may have immunosuppressive properties. To investigate the putative immunosuppressive properties of SAB, the anti-proliferation and suppression of early T cell activation markers, and the inhibition of cytokines induced by T cells in response to anti-CD3 mAb activation in mouse splenocytes were examined. The suppression of these activation repertoires are the main properties of calcineurin inhibitors. It was found that SAB effectively suppressed the activation of T cells, and cytokines from T cell activation, at levels similar to cyclosporine A, a calcineurin inhibitor. Although the mechanism in which suppression occurs is not clear, we speculate that SAB from Silurus asotus, which has been known to switch their intake habits to zoophagy during an early adult stage, may explain the suppressive effect of SAB as a result of high amounts of functional UDCA in bile. Our results suggest that the treatment or intake of SAB, either in therapy or as a food supplement, may act as an adjuvant therapy for the prevention of transplant rejection, although further investigation is required before this treatment can be applied clinically.

키워드

참고문헌

  1. Hagey LR, Crombie DL, Espinosa E, Carey MC, Igimi H, Hofmann AF. Ursodeoxycholic acid in the Ursidae: Biliary bile acids of bears, pandas, and related carnivores. J. Lipid Res. 34: 1911-1917 (1993)
  2. Calmus Y, Weill B, Ozier Y, Chéreau C, Houssin D, Poupon R. Immunosuppressive properties of chenodeoxycholic and ursodeoxycholic acids in the mouse. Gastroenterology 103: 617-621 (1992) https://doi.org/10.1016/0016-5085(92)90855-S
  3. Chen W, Gluud C. Bile acids for liver-transplanted patients. Cochrane Db. Syst. Rev. 20: CD005442 (2005)
  4. Rodrigues CMP, Fan G, Ma X, Kren BT, Steer CJ. A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation. J. Clin. Invest. 101: 2790- 2799 (1998) https://doi.org/10.1172/JCI1325
  5. Rodrigues CMP, Ma X, Linehan-Stieers C, Fan G, Kren BT, Steer CJ. Ursodeoxycholic acid prevents cytochrome c release in apoptosis by inhibiting mitochondrial membrane depolarization and channel formation. Cell Death Differ. 6: 842-854 (1999) https://doi.org/10.1038/sj.cdd.4400560
  6. Lacaille F, Paradis, K. The immunosuppressive effect of ursodeoxycholic acid: A comparative in vitro study on human peripheral blood mononuclear cells. Hepatology 18: 165-172 (1993)
  7. Gummert JF, Ikonen T, Morris RE. Newer immunosuppressive drugs: A review. J. Am. Soc. Nephrol. 10: 1366-1380 (1999)
  8. Joo SS, Won TJ, Lee DI. Potential role of ursodeoxycholic acid in suppression of nuclear factor kappa B in microglial cell line (BV-2). Arch. Pharm. Res. 27: 954-960 (2004) https://doi.org/10.1007/BF02975850
  9. Han JT, Lee SY, Lee YH, Baek NI. Antioxidative diarylheptanoids from the fruit of Alpinia oxyphylla. Food Sci. Biotechnol. 16: 1060- 1063 (2007)
  10. Hwang IG, Woo KS, Kim DJ, hong JT, Hwang BY, Lee YR, Jeong HS. Isolation and identification of an antioxidant substance from heated garlic (Allium sativim L.). Food Sci. Biotechnol. 16: 963-966 (2007)
  11. Kuhn DM, Balkis M, Chandra J, Mukherjee PK, Ghannoum MA. Uses and limitations of the XTT assay in studies of Candida growth and metabolism. J. Clin. Microbiol. 41: 506-508 (2003) https://doi.org/10.1128/JCM.41.1.506-508.2003
  12. Kim JH, Kim TW, Lee WY, Park SH, Kim HY. Multiplex PCR detection of the GT73, MS8xRF3, and T45 varieties of GM canola. Food Sci. Biotechnol. 16: 104-109 (2007)
  13. Aw MM. Transplant immunology. J. Pediatr. Surg. 38: 1275-1280 (2003) https://doi.org/10.1016/S0022-3468(03)00381-6
  14. Le Moine A, Goldman M, Abramowicz D. Multiple pathways to allograft rejection. Transplantation 73: 1373-1381 (2002) https://doi.org/10.1097/00007890-200205150-00001
  15. Saunders RN, Metcalf MS, Nicholson ML. Rapamycin in transplantation: A review of the evidence. Kidney Int. 59: 3-16 (2001) https://doi.org/10.1046/j.1523-1755.2001.00460.x
  16. Arat M, Idilman R, Soydan EA, Soykan I, Erden E, Karayalçin S, Akan H. Ursodeoxycholic acid treatment in isolated chronic graftvs.- host disease of the liver. Clin. Transplant. 19: 798-803 (2005) https://doi.org/10.1111/j.1399-0012.2005.00424.x
  17. Ishibashi H, Komori A, Shimoda S, Gershwin ME. Guidelines for therapy of autoimmune liver disease. Semin. Liver. Dis. 27: 214-226 (2007) https://doi.org/10.1055/s-2007-979472
  18. Palmeira CM, Rolo AP. Mitochondrially-meidated toxicity of bile acids. Toxicology 203: 1-15 (2004) https://doi.org/10.1016/j.tox.2004.06.001
  19. Alegre ML, Florquin S, Goldman M. Cellular mechanisms underlying acute graft rejection: Time for reassessment. Curr. Opin. Immunol. 19: 1-6 (2007) https://doi.org/10.1016/j.coi.2006.11.018
  20. Moschetta A, Xu F, Hagey LR, Berge-Henegouwen GP, Erpecum KL, Brouwers JF, Cohen JC, Bierman M, Hobbs HH, Steinbach JH, Hofmann AF. A phylogenetic survey of biliary lipids in vertebrates. J. Lipid Res. 46: 2221-2232 (2005) https://doi.org/10.1194/jlr.M500178-JLR200